SOURCE: Dynavax Technologies

Dynavax Technologies

February 27, 2015 16:59 ET

Dynavax to Present at the Cowen and Company 35th Annual Health Care Conference

BERKELEY, CA--(Marketwired - Feb 27, 2015) - Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that Eddie Gray, the Company's Chief Executive Officer, will present at the Cowen and Company 35th Annual Health Care Conference on Monday, March 2, 2015 at 1:30 PM Eastern Time at the Boston Marriott Copley Place Hotel in Boston.

A live webcast of the presentation will be available by visiting the "Investors" section of the Dynavax website or may be reached directly at: http://wsw.com/webcast/cowen22/dvax/

About Dynavax

Dynavax, a clinical-stage biopharmaceutical company, uses TLR biology to discover and develop novel vaccines and therapeutics in the areas of infectious and inflammatory diseases and oncology. Dynavax's lead product candidate is HEPLISAV-B, a Phase 3 investigational adult hepatitis B vaccine. For more information visit www.dynavax.com.

Contact Information

  • Contact:
    Michael Ostrach
    Chief Financial Officer
    510-665-7257
    Email Contact